The Role of a Clinical Pharmacist in Lifestyle Modification
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Estimating Summary of diabetes self-care activity (SDSCA)
研究概览
简要总结
The aims of this study are to determine the prevalence of diabetic peripheral neuropathy among the diabetic patients, to determine the association between the clinical profiles of the diabetic patients (diabetes type, diabetes duration, HbA1c, body mass index, hypertension, total cholesterol) and the diabetic peripheral neuropathy DPN and the rational poly pharmacy used to control pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Double (Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 18 years or older.
- •Diagnosed with type 2 diabetes at least one year previously.
- •Took at least one prescribed medication for diabetes.
- •Diagnosed as diabetic peripheral neuropathy based on clinical
排除标准
- •History of alcohol consumption.
- •Thyroid gland disorder.
- •Any kidney disorder.
- •Any conditions that could confound assessment of pain due to diabetic peripheral neuropathy.
- •Have foot injury or open sore.
- •Pregnant females or who plan to become pregnant during the study period.
- •Any serious medical condition that might prevent completion or hinder compliance with exercise.
研究组 & 干预措施
Intervention Group
The intervention group will receive the three months' lifestyle modification program by a clinical pharmacist.
干预措施: Diabetic patients with neuropathy (Other)
Usual care Group
The usual care group will be provided the standard medical services
结局指标
主要结局
Estimating Summary of diabetes self-care activity (SDSCA)
时间窗: Three months
Assessing Lifestyle modification by summary of diabetes self-care activity (SDSCA) at baseline visit and after three months for both Intervention patients and usual care group Increases in the means of the items of the scale as Exercise, Blood sugar testing, Specific diet and Foot care in the intervention group.
Adherence to treatment according to Morisky scale
时间窗: Three months
Morisky scale is used to assess medication adherence at baseline visit and after three months for both Intervention patients and usual care group. Improving the patient medication adherence behavior in the intervention group patients
Douleur Neuropathique 4 (DN4), Neuropathic Pain Scale (NPS),
时间窗: Three months
Reduction in the percent of response of patients feeling; electric shock, tingling, and pin needle after the lifestyle modification in the intervention group.
次要结局
未报告次要终点
研究者
Kawa Dizaye
Professor of Pharmacology
Hawler Medical University